National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 413 cases where Vaccine is HPV or HPV2 or HPV4 and Patient Died

Case Details

This is page 26 out of 42

Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next


VAERS ID: 517286 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2013-12-20
Entered: 2013-12-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1310GBR012338

Write-up: This spontaneous report as received from a consumer refers to a hearsay adverse experience. It was reported there was a death case in England a few years ago. It was indicated the reporter heard the news in year 2010 from TV and newspaper (a local newspaper). The reporter barely recalled there was 1 death case reporter and the brand of produce was barely recalled as GARDASIL. The reporter also mentioned her sister, also heard same death reports in 2010. (MARRS# 1311GBR000054). Additional information is not available.


VAERS ID: 525335 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-03-10
Entered: 2014-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1403NZL002674

Write-up: This spontaneous report as received from a immunisation nurse via a company representative, refers to a female patient of unknown age. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with GARDASIL (also reported as HPV vaccine). Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The nurse stated the female patient died "last month" (approximately in February 2014), and no other patient identifiers are available. The nurse mentioned the region where this reportedly occurred was "the same place where a girl''s death after GARDASIL vaccination was previously reported in December (MARRS # 1312NZL004481). No patient identifiers or additional information was available. The reporting nurse also advised that received information from another nurse, who had heard from someone else that one of the mothers in the area had recently not consented to her daughter being vaccinated with GARDASIL because "her cousin died from HPV vaccine about a month ago". The reporting nurse is trying to contact a total of 15 patients who had not consented to their daughters'' vaccination during that time, to identify the reporter of the above information. The nurse stated that the area is not the most highly populated area and she is trying to contact physicians in the area to confirm the report. The nurse stated that if there had been a death, she and her team would know about it. The reporting nurse "suspects very strongly that this is a duplicate case" (of MARRS # 1312NZL004481) with which she had been previously involved. The causality was not reported. Additional information has been requested.


VAERS ID: 526931 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-03-26
Entered: 2014-03-28
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1403RUS011092

Write-up: This spontaneous report as received from a physician via a company representative from social media refers to a several patients of unknown age and gender. On an unknown date, the several patients were vaccinated with GARDASIL (strength, dose, frequency, route, lot number and expiry date unknown). On an unknown date several patients died following vaccination (death). The outcome of several cases of death following vaccination was reported as fatal. Follow up information was received on 24-MAR-2014. According to the physician she saw the television six months ago, and there was a report on one female patient who died after receiving GARDASIL vaccine. In addition, she read in the Internet all kinds of articles around the "noise on GARDASIL" but did not remember exactly what. Additional information is not expected.


VAERS ID: 530376 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2013-01-02
Submitted: 2014-05-07
   Days after onset:489
Entered: 2014-05-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Acute disseminated encephalomyelitis, Death
SMQs:, Noninfectious encephalitis (narrow), Demyelination (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2013-05-13
   Days after onset: 130
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0990813A

Write-up: This case was reported by a consumer (subject''s relative) via a regulatory authority (ES-AGEMED-805461241) and described the occurrence of acute disseminated encephalomyelitis in a 15-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). In 2012, the subject received unspecified dose of CERVARIX (unknown route, injection site and batch number). On 2 January 2013, less than one year after vaccination with CERVARIX, the subject experienced acute disseminated encephalomyelitis. The subject was hospitalised and the regulatory authority reported that the event was disabling. On 13 May 2013, the subject died die to acute disseminated encephalomyelitis. It was unknown whether an autopsy was performed. The regulatory authority reported that the event was unlikely to be related to vaccination with CERVARIX.


VAERS ID: 535577 (history)  
Form: Version 1.0  
Age: 29.0  
Sex: Female  
Location: Foreign  
Vaccinated:2011-04-06
Onset:2012-01-21
   Days after vaccination:290
Submitted: 2014-07-01
   Days after onset:891
Entered: 2014-07-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA076EB / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Asthenia, Back pain, Biopsy cervix abnormal, Blood test, Cervical dysplasia, Cytology abnormal, Death, Exposure during pregnancy, Fatigue, Malaise, Metastasis, Papilloma viral infection, Smear cervix normal
SMQs:, Retroperitoneal fibrosis (broad), Reproductive premalignant disorders (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Guillain-Barre syndrome (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Uterine and fallopian tube malignant tumours (broad), Uterine and fallopian tube tumours of unspecified malignancy (broad), Non-haematological malignant tumours (narrow), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2012-01-21
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Cervical uterine dysplasia
Allergies:
Diagnostic Lab Data: Blood test, Dec2011, Not provided; Cervical biopsy, 21Mar2011, See text; Cervical cytology, 11Mar2011, Positive for hig; Cytology, 17Jan2011, Low grade sqamou; Cytology, 20Oct2011, See text; Laboratory test, Jan2014, Metastasis of un; On 21 March 2011, the cervical biopsy was performed which showed low grade squamous intraepithelial lesion with morphological changes related to Human Papilloma virus, Uterine cervical dysplasia; On 29 October 2011, cytology showed no malignant cells and cervical smear without dysplastic lesion
CDC Split Type: B1006932A

Write-up: This retrospective pregnancy case was reported by a consumer via a regulatory authority (# ES-AGEMED-205169340) and described the occurrence of metastasis in a 29-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 17 January 2011, cytology was performed which showed low grade squamous lesion (mild dysplasia). On 11 March 2011, a test to detect the papillomavirus in the cervical secretion was performed and the result was positive to high grade Human Papilloma virus (unknown the serotype of HPV) and a biopsy was recommended. On 21 March 2011, the cervical biopsy was performed which showed Low Grade Squamous Intraepithelial Lesion with morphological changes related to Human Papilloma virus (uterine cervical dysplasia). On 6 April 2011, the subject received 1st dose of CERVARIX, (.5 ml, intramuscular, unknown site of injection). In April 2011, less than a month after vaccination with CERVARIX, the subject experienced malaise, asthenia, fatigue and back pain. On 14 June 2011, the subject received 2nd dose of CERVARIX, (.5 ml, intramuscular, unknown site of injection). On 20 October 2011, the subject received 3rd dose of CERVARIX, (.5 mol, intramuscular, unknown site of injection). On the same day, after the administration of the 3rd dose of the vaccine, a new cytology was performed. On 2 November 2011, the results showed no malignant cells and cervical smear without dysplastic lesion. On 14 November 2011, the subject visited the gynaecologist where it was confirmed that the subject was pregnant from 1 month. The subject was pregnant at the time of 3rd vaccination with CERVARIX, leading to vaccine exposure during pregnancy. She went to the physician every week since November. The subject took paracetamol. No more tests were performed to determine the subject''s bad health conditions. In December 2011, the gynaecologist requested a new blood test due to the pregnancy. The pain was more intense. When the subject went to pick up the test results, the gynaecologist told that the subject had to go to the hospital. On 2 January 2012, the subject was hospitalized. On 21 January 2012, (19 days later) the subject died (while she was pregnant). During those 19, days several test were performed and the physicians told the family that she had metastasis of an unknown cause. It was unknown whether an autopsy was performed or not. The regulatory authority considered that metastasis, malaise, asthenia, fatigue and back pain were unlikely related to vaccination with CERVARIX.


VAERS ID: 543034 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2014-08-27
Submitted: 2014-09-09
   Days after onset:13
Entered: 2014-09-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2014-08-27
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1409KOR003270

Write-up: This spontaneous report as received from a physician via a field sales representative refers to a 11 or 12 year old female patient. The physician read an on-line document, source unspecified which stated that on an unknown date the patient was vaccinated with a dose of GARDASIL (strength, dose, route and lot# unknown). On 27-AUG-2014 the patient died after receiving GARDASIL. The cause of death was not reported. Additional information has been requested.


VAERS ID: 551754 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-10-23
Entered: 2014-10-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1410CAN011258

Write-up: Case 1 of 72. This spontaneous report as received from a nurse via a company sales representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL. No co-suspect or concomitant therapies reported. The nurse recently attended a conference on vaccinations in general. The physician who presented information on various vaccinations mentioned that there was 72 young girls who were vaccinated with GARDASIL and died due to thrombosis following vaccination (death). The cause of death was reported as thrombosis. The reporter considered death due to thrombosis following vaccination to be related to GARDASIL. Additional information was requested. 23-Oct-2014: The reporter has not further information regarding the patients.


VAERS ID: 551755 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-10-23
Entered: 2014-10-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1410CAN011499

Write-up: Case 3 of 72. This spontaneous report as received from a nurse via a company sales representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL. No co-suspect or concomitant therapies reported. The nurse recently attended a conference on vaccinations in general. The physician who presented information on various vaccinations mentioned that there was 72 young girls who were vaccinated with GARDASIL and died due to thrombosis following vaccination (death). The cause of death was reported as thrombosis. The reporter considered death due to thrombosis following vaccination to be related to GARDASIL. Additional information was requested. 23-Oct-2014: The reporter has not further information regarding the patients.


VAERS ID: 551768 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-10-23
Entered: 2014-10-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other information
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1410CAN011501

Write-up: Case 5 of 72. This spontaneous report as received from a nurse via a company sales representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL. No co-suspect or concomitant therapies reported. The nurse recently attended a conference on vaccinations in general. The physician who presented information on various vaccinations mentioned that there was 72 young girls who were vaccinated with GARDASIL and died due to thrombosis following vaccination (death). The cause of death was reported as thrombosis. The reporter considered death due to thrombosis following vaccination to be related to GARDASIL. Additional information was requested. 23-Oct-2014: The reporter has not further information regarding the patients. Additional information is not expected.


VAERS ID: 551776 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-10-23
Entered: 2014-10-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1410CAN011508

Write-up: This spontaneous report as received from a nurse via a company sales representative refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL. No co-suspect or concomitant therapies reported. The nurse recently attended a conference on vaccinations in general. The physician who presented information on various vaccinations mentioned that there was 72 young girls who were vaccinated with GARDASIL and died due to thrombosis following vaccination. The cause of death was reported as thrombosis. The reporter considered death due to thrombosis following vaccination to be related to GARDASIL. Additional information was requested. 23-Oct-2014: The reporter has no further information regarding the patients. Additional information is not expected.


Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=26&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4&DIED=Yes


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166